Pricing

SalioGen Therapeutics

1 follower

‌

SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.

Industries

Biotechnology, Education

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Jason F. Cole

CEO & Chairman

Jason F. Cole

Collapse

Will Mcgown

Executive Director, Finance & FP&A

Jill Murray

VP, Human Resources

Joseph J. Higgins

President & Chief Scientific Officer

Jeff Kopacz

SVP of Intellectual Property & Contracts

Joe Senn

SVP & Head of R&D

Jill Murray, PHR

Vice President Human Resources

William McGowan

Executive Director, Finance And Fp&a

Subhro Guhathakurta

Executive Director, Platform Development & Genetic Engineering

LauraLee Hughes

Director, Corporate Development & Strategy

Pat Sacco

SVP of Manufacturing, Quality & Operations

Board & advisors

Director

Director

Scientific Advisor

Scientific Advisor

Scientific Advisor

Scientific Advisor

Scientific Advisor

Advisor

Advisor

Advisor

Teams

+11

Scientific Advisory and Development

14 members

Scientific Research

7 members

Leadership Team

6 members

Offices

Similar companies

Kura Oncology

20 followers

Eikon Therapeutics

1 follower

PathAI

58 followers

Halozyme Therapeutics

6 followers

Immunovant

6 followers

REVOLUTION Medicines

5 followers

C4 Therapeutics

5 followers

Summit Therapeutics

5 followers

Product School

5 followers

Inari

3 followers

Beta Bionics

3 followers

Explore companies